Acerus Biopharma Inc. logo

Acerus Biopharma Inc.

3 Live Marks
9 on record
Corp.
First Filed:Oct 7, 2013Latest Filed:Sep 15, 2022Address:7025 Langer Drive, Suite 205, Mississauga, Ontario, L5N0E8, CA

Portfolio Overview

Top Classes

Class 5
Pharmaceuticals
8(89%)
Class 10
Medical Apparatus
2(22%)
Class 16
Paper Goods and Printed Matter
1(11%)

TTAB Proceedings

No litigation activity

Top Firms

Banner & Witcoff, Ltd.(Sep 2022)
5
Greenberg Traurig, LLP(Mar 2019)
4

Trademark Portfolio

9 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
TRIVAIR DEPOSITION SYSTEM
TRIVAIR DEPOSITION SYSTEM
Trademark
Combined
ABANDONED
Owner:
Serial:97593472
Filed:Sep 15, 2022
Classes:5, 10
Description: Inhalers filled with pharmaceutical preparations for use in the treatment of respiratory diseases; Medical apparatus and instruments, namely, inhalers, sold empty, for therapeutic use in the administering of pharmaceutical preparations
TESTOSTEROWN
TESTOSTEROWN
Trademark
Word
REGISTERED
Owner:
Serial:90095710
Filed:Aug 5, 2020
Classes:16, 44
Registration:6357861
Registered:May 18, 2021
Description: Class 16: Printed matter, namely, pamphlets, brochures, newsletters, manuals, booklets, leaflets, charts, catalogues, paper displays and posters relating to pharmaceutical treatment and management of diseases or conditions related to testosterone deficiency
Class 44: Medical information services, namely, providing information relating to pharmaceutical treatment and management of diseases or conditions related to testosterone deficiency; providing information relating to pharmaceutical treatment and management of diseases or conditions related to testosterone deficiency via a website
NATESTO N
NATESTO N
Trademark
Combined
REGISTERED
Owner:
Serial:90002018
Filed:Jun 15, 2020
Classes:5
Registration:6350052
Registered:May 11, 2021
Description: Pharmaceutical preparations, namely, testosterone supplementation
TRIVAIR
TRIVAIR
Trademark
Word
ABANDONED
Owner:
Serial:88830833
Filed:Mar 11, 2020
Classes:5, 10
Description: Class 5: Inhalers filled with pharmaceutical preparations for use in the treatment of respiratory diseases, disorders and infections; inhalers filled with pharmaceutical preparations for use in the treatment of asthma; inhalers filled with pharmaceutical preparations for use in the treatment of chronic obstructive pulmonary disease; inhalers filled with pharmaceutical preparations for use in the treatment of rhinitis; inhalers filled with pharmaceutical preparations for use in the treatment of sinus polyps; inhalers filled with pharmaceutical preparations for use in the treatment of viral airway infections; inhalers filled with pharmaceutical preparations for use in the treatment of multiple sclerosis; inhalers filled with pharmaceutical preparations for use in the treatment of depression; inhalers filled with pharmaceutical preparations for use in the treatment of epilepsy; inhalers filled with pharmaceutical preparations for use in the treatment of migraine; inhalers filled with pharmaceutical preparations for use in the treatment of Alzheimer's disease; inhalers filled with pharmaceutical preparations for use in the treatment of Parkinson's disease; inhalers filled with pharmaceutical preparations for use in the treatment of cerebrovascular accident or stroke; inhalers filled with pharmaceutical preparations for use in the treatment of traumatic brain injury; inhalers filled with pharmaceutical preparations for use in the treatment of cancer; inhalers filled with pharmaceutical preparations for use in the treatment of nausea; inhalers filled with pharmaceutical preparations for use in the treatment of post-traumatic stress disorder; inhalers filled with pharmaceutical preparations for use in the treatment of amyotrophic lateral sclerosis; inhalers filled with pharmaceutical preparations for use in the treatment of chronic pain; inhalers filled with pharmaceutical preparations for use in the treatment of insomnia; inhalers filled with pharmaceutical preparations for use in the relief of pain; inhalers filled with pharmaceutical preparations for use in the treatment of cough or sore throat; inhalers filled with pharmaceutical preparations for use in the treatment of candida infection; inhalers filled with pharmaceutical preparations for use in anti-fungal treatment; inhalers filled with pharmaceutical preparations for use in sedation; inhalers filled with pharmaceutical preparations for use in hormone replacement therapy; inhalers filled with pharmaceutical preparations for use in the treatment of psychosis; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of respiratory diseases, disorders and infections; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of asthma; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of chronic obstructive pulmonary disease; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of rhinitis; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of sinus polyps; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of viral airway infections; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of multiple sclerosis; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of depression; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of epilepsy; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of migraine; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of Alzheimer's disease; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of Parkinson's disease; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of cerebrovascular accident or stroke; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of traumatic brain injury; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of cancer; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of nausea; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of post-traumatic stress disorder; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of amyotrophic lateral sclerosis; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of chronic pain; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of insomnia; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the relief of pain; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of cough or sore throat; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of candida infection; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in anti-fungal treatment; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in sedation; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in hormone replacement therapy; drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of psychosis; inhalers used to deliver therapeutic agents, namely, analgesics, sedatives, vaccines, anesthetics, insulin, antiemetics, antifungals, hormones, or antipsychotics; drug delivery devices, namely, breath actuated nasal delivery devices used to deliver therapeutic agents, namely, analgesics, sedatives, vaccines, anesthetics, insulin, antiemetics, antifungals, hormones, or antipsychotics; inhalers filled with analgesics, sedatives, vaccines, anesthetics, insulin, antiemetics, antifungals, hormones, respiratory therapeutic agents, or antipsychotics; drug delivery devices, namely, breath actuated nasal delivery devices filled with analgesics, sedatives, vaccines, anesthetics, insulin, antiemetics, antifungals, hormones, respiratory therapeutic agents, or antipsychotics; none of the foregoing containing cannabis or CBD
Class 10: Medical apparatus and instruments, namely, inhalers, sold empty, for therapeutic use; medical apparatus and instruments, namely, breath actuated nasal drug delivery devices, sold empty, for therapeutic use; none of the foregoing for use with cannabis or CBD
TEFINA
TEFINA
Trademark
Word
ABANDONED
Owner:
Serial:88350154
Filed:Mar 21, 2019
Classes:5
TRI AIR DEPOSITION SYSTEM
TRI AIR DEPOSITION SYSTEM
Trademark
Combined
ABANDONED
Owner:
Serial:88117654
Filed:Sep 14, 2018
Classes:5
Description: "AIR" AND "DEPOSITION SYSTEM"
TEFINA
TEFINA
Trademark
Word
ABANDONED
Owner:
Serial:86743050
Filed:Aug 31, 2015
Classes:5
TRI AIR DEPOSITION SYSTEM
TRI AIR DEPOSITION SYSTEM
Trademark
Combined
ABANDONED
Owner:
Serial:86497842
Filed:Jan 7, 2015
Classes:5
Description: "AIR", "DEPOSITION", OR "SYSTEM"
NATESTO
NATESTO
Trademark
Word
REGISTERED
Owner:
Serial:86084664
Filed:Oct 7, 2013
Classes:5
Registration:4761006
Registered:Jun 23, 2015
Description: Pharmaceutical preparations, namely, testosterone supplementation